Finance

Lists
SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$2.51
-6.34%
(-0.17) 1D
$2.50
-0.40% (-0.0100)
After hours
Closed: Aug 28, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SCNI...
Open
$2.70
High
$2.98
Low
$2.33
Mkt. cap
1.43M
Avg. vol.
70.93K
Volume
37.50K
52-wk high
$16.80
52-wk low
$2.15
EPS
-$180.40
Beta
2.08
Shares outstanding
51.69K
No. of employees
45
Open
$2.70
High
$2.98
Low
$2.33
Mkt. cap
1.43M
Avg. vol.
70.93K
Volume
37.50K
52-wk high
$16.80
52-wk low
$2.15
EPS
-$180.40
Beta
2.08
Shares outstanding
51.69K
No. of employees
45
News stories
From web sources and news partners
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR
CEO-
Employees45
FoundedJan 1, 2003
Headquarters-
SectorBiotechnology
Websitescinai.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
269.00K
269.00K
489.00K
460.00K
Cost of goods sold
960.00K
960.00K
1.61M
1.71M
Cost of revenue
960.00K
960.00K
1.61M
1.71M
Research and development expenses
566.00K
566.00K
628.00K
211.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
632.50K
632.50K
721.00K
683.00K
Operating expense
1.20M
1.20M
1.35M
894.00K
Total operating expenses
2.16M
2.16M
2.96M
2.61M
Operating income
-1.89M
-1.89M
-2.47M
-2.15M
Other non operating income
-3.50K
-3.50K
-
-
EBT including unusual items
-2.09M
-2.09M
3.58M
-2.00M
EBT excluding unusual items
-2.09M
-2.09M
-2.58M
-2.25M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.09M
-2.09M
3.58M
-2.00M
Net profit margin
-775.65%
-775.65%
731.49%
-435.43%
Earnings per share
-
-
-
-
Interest and investment income
16.00K
16.00K
-
-
Interest expense
-
-
-112.00K
-102.00K
Net interest expenses
16.00K
16.00K
-112.00K
-102.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.53M
-1.53M
-2.01M
-1.56M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps